Wilson Sonsini Goodrich & Rosati advised IGM on the transaction.IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its non-voting…
IGM Biosciences’ $230 Million Public Offering


Wilson Sonsini Goodrich & Rosati advised IGM on the transaction.IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its non-voting…
…